THE USE OF GINSENOSIDE Rg1, ITS METABOLITES GINSENOSIDE Rh1 AND/OR PpT

(19)

(11)

EP 2 133 082 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.07.2014 Bulletin 2014/29

(45)	Mention of the grant of the patent:
	11.06.2014 Bulletin 2014/24

(21)	Application number: 07846012.8

(22)	Date of filing: 25.12.2007

(51)

International Patent Classification (IPC):

A61K 31/704^(2006.01)
A61P 15/10^(2006.01)

A61P 15/08^(2006.01)

(86)	International application number:
	PCT/CN2007/003776

(87)	International publication number:
	WO 2008/110050 (18.09.2008 Gazette 2008/38)

(54)	THE USE OF GINSENOSIDE Rg1, ITS METABOLITES GINSENOSIDE Rh1 AND/OR PpT VERWENDUNG VON GINSENOSID RG1, SEINER METABOLITEN GINSENOSID RH1 UND/ODER PPT UTILISATION DE GINSENOSIDE Rg1 ET/OU DE SES MÉTABOLITES GINSENOSIDE Rh1 ET PpT

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30)

Priority:

12.03.2007 CN 200710064326

(43)	Date of publication of application:
	16.12.2009 Bulletin 2009/51

(73)	Proprietors:
	Jecui Health Industry Corp. Ltd. Chuxiong Yunnan 675000 (CN) Institute of Materia Medica, Chinese Academy of Medical Sciences Beijing 100050 (CN)

(72)	Inventors:
	ZHANG, Juntian Beijing 100050 (CN) CHU, Shifeng Beijing 100050 (CN)

(74)	Representative: Sajda, Wolf E. et al
	Meissner, Bolte & Partner GbR Postfach 86 06 24 81633 München 81633 München (DE)

(56)

References cited: :

WO-A-2006/001654
CN-A- 1 732 963
US-B1- 6 444 237

CN-A- 1 425 382
CN-A- 1 795 868

YOSHIMURA H ET AL: "Preventive effects of various ginseng saponins on the development of copulatory disorder induced by prolonged individual housing in male" METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, PROUS, BARCELONA, ES, vol. 20, no. 1, 1 January 1998 (1998-01-01), pages 59-64, XP009129191 ISSN: 0379-0355
HAO J. ET AL.: 'Ginsenoside Rg1 Protect against Cadmium-induced Testicular Damage in Rat' JOURNAL OF CHONGQING MEDICAL UNIVERSITY (IN CHINESE) vol. 32, no. 3, March 2007, pages 236 - 238, XP008136226
WANG Y. ET AL.: 'Studies on the Metabolism of Ginsenoside Rg1 by Intestinal Bacteria and its Absorbed Metabolites in Rat and Human Sera' ACTA PHARMACEUTICA SINICA vol. 35, no. 4, April 2000, pages 284 - 288, XP008118048

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).